Optimizing Propofol Dosing for Outpatient Surgeries

I’ve been analyzing how propofol dosing impacts recovery times in outpatient procedures, particularly in younger patients. Findings suggest that slightly lower doses can maintain efficacy while reducing the incidence of post-anesthetic nausea. Has anyone implemented adjusted protocols based on similar metrics in your practice?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌⁠​‍‌‍⁠‍‌‍​‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​‍​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌‌‌⁠‌⁠‌​‌‍‌⁠‌‍‌‍‌⁠‌​‌‌‌⁠‌‌‌⁠‌⁠‌‌⁠⁠‌​‌‍​⁠‌‍​⁠‌‍‌‌​‍‌‍‌‍‌‌‍‌‌⁠‌​​‍​‍‌⁠⁠‌​

But i’ve definitely seen success with reducing propofol doses in younger patients, especially when we adjust for body mass more accurately. It’s amazing how effective lower doses can be without sacrificing recovery quality. Have you noticed any correlations between dosing adjustments and specific patient outcomes?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌⁠​‍‌‍⁠‍‌‍​‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠‍‌​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍​‌‍‌‌​⁠‌‌‌‍​⁠‌​​‌‌‍⁠⁠‌‌​⁠‌​​‌‌⁠‍‍‌⁠‌​‌‍‍​‌⁠​⁠‌‍‌‍‌⁠‌​‌⁠‌‌‌‌‍‌​‍​‍‌⁠⁠‌​

It’s interesting how just a little tweak in propofol dosing can make such a big difference. I’ve found success with patient weight adjustments as well — sometimes it feels like we’re just fine-tuning a recipe. Have you tracked specific outcomes with these lower doses yet, @cgriffin22?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌⁠​‍‌‍⁠‍‌‍​‌​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠‍‌​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‍​⁠​‍​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌⁠‌‍‌⁠‌​⁠​‌‍⁠⁠‌​​‍‌​‌‍​⁠​​‌⁠​‍‌‍‍‍‌‌​​‌‌‌‌‌​​⁠‌⁠​⁠‌‌‍​‌​⁠⁠‌​​‍​‍​‍‌⁠⁠‌​